Advertisement

Pathologie pp 717-792 | Cite as

Herpesvirus-assoziierte lymphoproliferative Erkrankungen und maligne Lymphome

  • Ioannis Anagnostopoulos
  • Leticia Quintanilla de Fend
Chapter

Zusammenfassung

Ebstein Barr Virus (EBV) und das humane Herpesvirus 8 (HHV8) sind die wichtigsten Tumorviren des Menschen in westlichen Ländern. Dabei entstehen lymphoproliferative Erkrankungen und maligne Lymphome durch eine fehlende oder mangelhafte immunologische Bewältigung der primären oder meist üblichen latenten Infektionen. In diesem Kapitel werden die sehr unterschiedlichen Entitäten mit Virusnachweis in den neoplastischen B-, NK- oder T-Zellen, sowie die Beziehung zu verschiedenen Formen der gestörten Viruselimination und Immundefizienz dargestellt.

Literatur

  1. 1.
    Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, Beier R, Schaffer AA, Gertz EM, Schambach A, Kreipe HH, Pfeifer D, Engelhardt KR, Rezaei N, Grimbacher B, Lohrmann S, Sherkat R, Klein C (2012) The phenotype of human STK4 deficiency. Blood 119:3450–3457PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Adams H, Campidelli C, Dirnhofer S, Pileri SA, Tzankov A (2009) Clinical, phenotypic and genetic similarities and disparities between post-transplant and classical Hodgkin lymphomas with respect to therapeutic targets. Expert Opin Ther Targets 13:1137–1145PubMedCrossRefGoogle Scholar
  3. 3.
    Aguilar C, Beltran B, Quinones P, Carbajal T, Vilcapaza J, Yabar A, Segura P, Quintanilla-Martinez L, Miranda RN, Castillo JJ (2015) Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus? Cardiovasc Pathol 24:60–64PubMedCrossRefGoogle Scholar
  4. 4.
    Alexanian S, Said J, Lones M, Pullarkat ST (2013) KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states. Am J Surg Pathol 37:241–249PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Ando M, Sato Y, Takata K, Nomoto J, Nakamura S, Ohshima K, Takeuchi T, Orita Y, Kobayashi Y, Yoshino T (2013) A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas. PLoS ONE 8:e56741PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Angulo I, Vadas O, Garcon F, Banham-Hall E, Plagnol V, Leahy TR, Baxendale H, Coulter T, Curtis J, Wu C, Blake-Palmer K, Perisic O, Smyth D, Maes M, Fiddler C, Juss J, Cilliers D, Markelj G, Chandra A, Farmer G, Kielkowska A, Clark J, Kracker S, Debre M, Picard C, Pellier I, Jabado N, Morris JA, Barcenas-Morales G, Fischer A, Stephens L, Hawkins P, Barrett JC, Abinun M, Clatworthy M, Durandy A, Doffinger R, Chilvers ER, Cant AJ, Kumararatne D, Okkenhaug K, Williams RL, Condliffe A, Nejentsev S (2013) Phosphoinositide 3. Kinase Delta Gene Mutat Predisposes To Respir Infect Airw Damage Sci 342:866–871Google Scholar
  7. 7.
    Ansari MQ, Dawson DB, Nador R, Rutherford C, Schneider NR, Latimer MJ, Picker L, Knowles DM, McKenna RW (1996) Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 105:221–229PubMedCrossRefGoogle Scholar
  8. 8.
    Aoukaty A, Lee IF, Wu J, Tan R (2003) Chronic active Epstein-Barr virus infection associated with low expression of leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) on natural killer cells. J Clin Immunol 23:141–145PubMedCrossRefGoogle Scholar
  9. 9.
    Aozasa K, Takakuwa T, Nakatsuka S (2005) Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation. Adv Anat Pathol 12:324–331PubMedCrossRefGoogle Scholar
  10. 10.
    Arias C, Weisburd B, Stern-Ginossar N, Mercier A, Madrid AS, Bellare P, Holdorf M, Weissman JS, Ganem D (2014) KSHV 2.0: a comprehensive annotation of the Kaposi’s sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features. Plos Pathog 10:e1003847PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Armes JE, Angus P, Southey MC, Battaglia SE, Ross BC, Jones RM, Venter DJ (1994) Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Cancer 74:2436–2441PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Arzoo KK, Bu X, Espina BM, Seneviratne L, Nathwani B, Levine AM (2004) T-cell lymphoma in HIV-infected patients. J Acquir Immune Defic Syndr 36:1020–1027PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Asada H (2007) Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis. J Dermatol Sci 45:153–160PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Asada H, Saito-Katsuragi M, Niizeki H, Yoshioka A, Suguri S, Isonokami M, Aoki T, Ishihara S, Tokura Y, Iwatsuki K, Miyagawa S (2005) Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4 T cells in patients with hypersensitivity to mosquito bites. J Invest Dermatol 125:956–961PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Asou H, Said JW, Yang R, Munker R, Park DJ, Kamada N, Koeffler HP (1998) Mechanisms of growth control of Kaposi’s sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood 91:2475–2481PubMedPubMedCentralGoogle Scholar
  16. 16.
    Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO, Liang R (2009) Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113:3931–3937CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Baecklund E, Smedby KE, Sutton LA, Askling J, Rosenquist R (2014) Lymphoma development in patients with autoimmune and inflammatory disorders – what are the driving forces? Semin Cancer Biol 24:61–70CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ, Homan van der Heide JJ, Veeger NJ, Kluin PM, Kluin-Nelemans HC (2005) Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant 19:327–334PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Barrionuevo C, Anderson VM, Zevallos-Giampietri E, Zaharia M, Misad O, Bravo F, Caceres H, Taxa L, Martinez MT, Wachtel A, Piris MA (2002) Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. Appl Immunohistochem Mol Morphol 10:7–14PubMedPubMedCentralGoogle Scholar
  20. 20.
    Barta SK, Samuel MS, Xue X, Wang D, Lee JY, Mounier N, Ribera JM, Spina M, Tirelli U, Weiss R, Galicier L, Boue F, Little RF, Dunleavy K, Wilson WH, Wyen C, Remick SC, Kaplan LD, Ratner L, Noy A, Sparano JA Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma. Ann Oncol 26:958–966PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Beltran BE, Castillo JJ, Morales D, de Mendoza FH, Quinones P, Miranda RN, Gallo A, Lopez-Ilasaca M, Butera JN, Sotomayor EM (2011) EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru. Am J Hematol 86:663–667PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Beltran BE, Morales D, Quinones P, Medeiros LJ, Miranda RN, Castillo JJ (2011) EBV-positive diffuse large b-cell lymphoma in young immunocompetent individuals. Clin Lymphoma Myeloma Leuk 11:512–516PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Beylot-Barry M, Vergier B, Masquelier B, Bagot M, Joly P, Souteyrand P, Vaillant L, Avril MF, Franck N, Fraitag S, Delaunay M, Laroche L, Esteve E, Courville P, Dechelotte P, Beylot C, De Mascarel A, Wechsler J, Merlio JP (1999) The Spectrum of Cutaneous Lymphomas in HIV infection: a study of 21 cases. Am J Surg Pathol 23:1208–1216PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Boroumand N, Ly TL, Sonstein J, Medeiros LJ (2012) Microscopic diffuse large B-cell lymphoma (DLBCL) occurring in pseudocysts: do these tumors belong to the category of DLBCL associated with chronic inflammation? Am J Surg Pathol 36:1074–1080PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Boshoff C, Weiss RA (2001) Epidemiology and pathogenesis of Kaposi’s sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 356:517–534PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Cai Q, Verma SC, Lu J, Robertson ES (2010) Molecular biology of Kaposi’s sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res 78:87–142PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K (2005) Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 80:1233–1243PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Caillard S, Lelong C, Pessione F, Moulin B (2006) Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry. Am J Transplant 6:2735–2742PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Callen JP (2007) Complications and adverse reactions in the use of newer biologic agents. Semin Cutan Med Surg 26:6–14PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Camilleri-Broet S, Davi F, Feuillard J, Seilhean D, Michiels JF, Brousset P, Epardeau B, Navratil E, Mokhtari K, Bourgeois C, Marelle L, Raphael M, Hauw JJ (1997) AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors. Hum Pathol 28:367–374PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Canioni D, Arnulf B, Asso-Bonnet M, Raphael M, Brousse N (2001) Nasal natural killer lymphoma associated with Epstein-Barr virus in a patient infected with human immunodeficiency virus. Arch Pathol Lab Med 125:660–662PubMedPubMedCentralGoogle Scholar
  32. 32.
    Cannons JL, Tangye SG, Schwartzberg PL (2011) SLAM family receptors and SAP adaptors in immunity. Annu Rev Immunol 29:665–705PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Capello D, Cerri M, Muti G, Lucioni M, Oreste P, Gloghini A, Berra E, Deambrogi C, Franceschetti S, Rossi D, Alabiso O, Morra E, Rambaldi A, Carbone A, Paulli M, Gaidano G (2006) Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders. Hematol Oncol 24:212–219PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Capello D, Rossi D, Gaidano G (2005) Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis. Hematol Oncol 23:61–67PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Carbone A (2002) AIDS-related non-Hodgkin’s lymphomas: from pathology and molecular pathogenesis to treatment. Hum Pathol 33:392–404PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    A, De Paoli P, Gloghini A, Vaccher E (2015) KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies. International journal of cancer 137: 251–261Google Scholar
  37. 37.
    Carbone A, Gloghini A, Vaccher E, Marchetti G, Gaidano G, Tirelli U (2005) KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype. J Clin Pathol 58:1039–1045PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Castillo J, Pantanowitz L, Dezube BJ (2008) HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 83:804–809PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Castillo JJ, Bibas M, Miranda RN (2015) The biology and treatment of plasmablastic lymphoma. Blood 125:2323–2330PubMedCrossRefGoogle Scholar
  40. 40.
    Castleman B, Iverson L, Menendez VP (1956) Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9:822–830PubMedCrossRefGoogle Scholar
  41. 41.
    Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM (1998) BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood 92:2294–2302PubMedGoogle Scholar
  42. 42.
    Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186–1191PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Chadburn A, Chen JM, Hsu DT, Frizzera G, Cesarman E , Garrett TJ, Mears JG, Zangwill SD, Addonizio LJ, Michler RE, Knowles DM (1998) The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer 82:1978–1987PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E (2009) Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol 27:5039–5048PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM (2004) KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 28:1401–1416PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Chadburn A, Suciu-Foca N, Cesarman E, Reed E, Michler RE, Knowles DM (1995) Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol 147:1862–1870PubMedPubMedCentralGoogle Scholar
  47. 47.
    Chan JK (1998) Natural killer cell neoplasms. Anat Pathol 3:77–145PubMedPubMedCentralGoogle Scholar
  48. 48.
    Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH (1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89:4501–4513PubMedPubMedCentralGoogle Scholar
  49. 49.
    Chan JK, Tsang WY, Lau WH, Cheung MM, Ng WF, Yuen WC, Ng CS (1996) Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer 77:1198–1205PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Chandrakasan S, Filipovich AH (2013) Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment. J Pediatr 163:1253–1259PubMedCrossRefGoogle Scholar
  51. 51.
    Chang SE, Yoon GS, Huh J, Choi JH, Sung KJ, Moon KC, Koh JK (2002) Comparison of primary and secondary cutaneous CD56+ NK/T cell lymphomas. Appl Immunohistochem Mol Morphol 10:163–170PubMedGoogle Scholar
  52. 52.
    Chao C, Silverberg MJ, Martinez-Maza O, Chi M, Abrams DI, Haque R, Zha HD, McGuire M, Xu L, Said J (2012) Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma. Clin Cancer Res 18:4702–4712PubMedCrossRefGoogle Scholar
  53. 53.
    Chao C, Silverberg MJ, Xu L, Chen LH, Castor B, Martinez-Maza O, Abrams DI, Zha HD, Haque R, Said J (2015) A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection. Clin Cancer Res 21:1429–1437PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Chao C, Xu L, Silverberg MJ, Martinez-Maza O, Chen LH, Castor B, Abrams DI, Zha HD, Haque R, Said J (2015) Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival. AIDS 29:1943–1951PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Chen BJ, Chapuy B, Ouyang J, Sun HH, Roemer MG, Xu ML, Yu H, Fletcher CD, Freeman GJ, Shipp MA, Rodig SJ (2013) PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clin Cancer Res 19:3462–3473PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Chen CJ, Hsu WL, Yang HI, Lee MH, Chen HC, Chien YC, You SL (2014) Epidemiology of virus infection and human cancer. Recent Results Cancer Res 193:11–32PubMedCrossRefGoogle Scholar
  57. 57.
    Chen JS, Lin KH, Lin DT, Chen RL, Jou ST, Su IJ (1998) Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide-containing regimens. Br J Haematol 103:756–762PubMedCrossRefGoogle Scholar
  58. 58.
    Cheuk W, Chan AC, Chan JK, Lau GT, Chan VN, Yiu HH (2005) Metallic implant-associated lymphoma: a distinct subgroup of large B-cell lymphoma related to pyothorax-associated lymphoma? Am J Surg Pathol 29:832–836PubMedCrossRefGoogle Scholar
  59. 59.
    Chim CS, Ma ES, Loong F, Kwong YL (2005) Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvement. J Clin Pathol 58:443–445PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Chinnock R, Webber SA, Dipchand AI, Brown RN, George JF (2012) A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients. Am J Transplant 12:3061–3068PubMedCrossRefGoogle Scholar
  61. 61.
    Cho KH, Kim CW, Heo DS, Lee DS, Choi WW, Rim JH, Han WS (2001) Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions. Clin Exp Dermatol 26:242–247PubMedCrossRefGoogle Scholar
  62. 62.
    Chuang HC, Lay JD, Chuang SE, Hsieh WC, Chang Y, Su IJ (2007) Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome. Am J Pathol 170:1607–1617PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Chuang HC, Lay JD, Hsieh WC, Su IJ (2007) Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target. Cancer Sci 98:1281–1287PubMedCrossRefGoogle Scholar
  64. 64.
    Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, Weisenburger DD, Martinez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA (2013) Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer 109:280–288PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Cohen M, Narbaitz M, Metrebian F, De Matteo E, Preciado MV, Chabay PA (2014) Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients. Int J Cancer 135:2816–2824PubMedCrossRefGoogle Scholar
  66. 66.
    Copie-Bergman C, Niedobitek G, Mangham DC, Selves J, Baloch K, Diss TC, Knowles DN, Delsol G, Isaacson PG (1997) Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation. J Pathol 183:287–292PubMedCrossRefGoogle Scholar
  67. 67.
    Coupland SE, Charlotte F, Mansour G, Maloum K, Hummel M, Stein H (2005) HHV-8-associated T-cell lymphoma in a lymph node with concurrent peritoneal effusion in an HIV-positive man. Am J Surg Pathol 29:647–652PubMedCrossRefGoogle Scholar
  68. 68.
    Courville EL, Sohani AR, Hasserjian RP, Zukerberg LR, Harris NL, Ferry JA (2014) Diverse clinicopathologic features in human herpesvirus 8-associated lymphomas lead to diagnostic problems. Am J Clin Pathol 142:816–829PubMedCrossRefGoogle Scholar
  69. 69.
    Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ (1999) Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 94:2208–2216PubMedGoogle Scholar
  70. 70.
    Davi F, Delecluse HJ, Guiet P, Gabarre J, Fayon A, Gentilhomme O, Felman P, Bayle C, Berger F, Audouin J, Bryon PA, Diebold J, Raphael M (1998) Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin’s lymphomas. Burkitt’s Lymphoma Study Group. J Clin Oncol 16:3788–3795PubMedCrossRefGoogle Scholar
  71. 71.
    Demachi A, Nagata H, Morio T, Oyoshi MK, Zhang Y, Tabata N, Kimura N, Shimizu N, Yamamoto K (2003) Characterization of Epstein-Barr virus (EBV)-positive NK cells isolated from hydroa vacciniforme-like eruptions. Microbiol Immunol 47:543–552PubMedCrossRefGoogle Scholar
  72. 72.
    DePond W, Said JW, Tasaka T, de Vos S, Kahn D, Cesarman E, Knowles DM, Koeffler HP (1997) Kaposi’s sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. Am J Surg Pathol 21:719–724PubMedCrossRefGoogle Scholar
  73. 73.
    Dharnidharka VR, Tejani AH, Ho PL, Harmon WE (2002) Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk. Am J Transplant 2:993–998PubMedCrossRefGoogle Scholar
  74. 74.
    Dirmeier U, Hoffmann R, Kilger E, Schultheiss U, Briseno C, Gires O, Kieser A, Eick D, Sugden B, Hammerschmidt W (2005) Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24:1711–1717PubMedCrossRefGoogle Scholar
  75. 75.
    Dojcinov SD, Venkataraman G, Pittaluga S, Wlodarska I, Schrager JA, Raffeld M, Hills RK, Jaffe ES (2011) Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood 117:4726–4735PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Dojcinov SD, Venkataraman G, Raffeld M, Pittaluga S, Jaffe ES (2010) EBV positive mucocutaneous ulcer – a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34:405–417PubMedCrossRefGoogle Scholar
  77. 77.
    Dong Z, Davidson D, Perez-Quintero LA, Kurosaki T, Swat W, Veillette A (2012) The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells. Immunity 36:974–985PubMedCrossRefGoogle Scholar
  78. 78.
    Dossier A, Meignin V, Fieschi C, Boutboul D, Oksenhendler E, Galicier L (2013) Human herpesvirus 8-related Castleman disease in the absence of HIV infection. Clin Infect Dis 56:833–842PubMedCrossRefGoogle Scholar
  79. 79.
    Dotti G, Fiocchi R, Motta T, Facchinetti B, Chiodini B, Borleri GM, Gavazzeni G, Barbui T, Rambaldi A (1999) Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia 13:664–670PubMedCrossRefGoogle Scholar
  80. 80.
    Doyle TJ, Venkatachalam KK, Maeda K, Saeed SM, Tilchen EJ (1983) Hodgkin’s disease in renal transplant recipients. Cancer 51:245–247PubMedCrossRefGoogle Scholar
  81. 81.
    Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabecadas J, Dong HY, Harris NL, Chan JK, Rees JW, Dogan A, Isaacson PG (2002) KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood 100:3415–3418PubMedCrossRefGoogle Scholar
  82. 82.
    Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG (2001) Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97:2130–2136PubMedCrossRefGoogle Scholar
  83. 83.
    Du S, Scuderi R, Malicki DM, Willert J, Bastian J, Weidner N (2011) Hodgkin’s and non-Hodgkin’s lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature. Pediatr Dev Pathol 14:64–70PubMedCrossRefGoogle Scholar
  84. 84.
    Dulai PS, Thompson KD, Blunt HB, Dubinsky MC, Siegel CA (2014) Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review. Clin Gastroenterol Hepatol 12:1443–1451 (quiz e1488–1449)PubMedCrossRefGoogle Scholar
  85. 85.
    Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA, Steinberg SM, Yarchoan R, Jaffe ES, Wilson WH (2010) The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood 115:3017–3024PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95:1406–1412PubMedGoogle Scholar
  87. 87.
    Dupre L, Andolfi G, Tangye SG, Clementi R, Locatelli F, Arico M, Aiuti A, Roncarolo MG (2005) SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood 105:4383–4389PubMedCrossRefGoogle Scholar
  88. 88.
    Edelman DC (2005) Human herpesvirus 8 – a novel human pathogen. Virol J 2:78PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Eidenschenk C, Dunne J, Jouanguy E, Fourlinnie C, Gineau L, Bacq D, McMahon C, Smith O, Casanova JL, Abel L, Feighery C (2006) A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am J Hum Genet 78:721–727PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Enders A, Fisch P, Schwarz K, Duffner U, Pannicke U, Nikolopoulos E, Peters A, Orlowska-Volk M, Schindler D, Friedrich W, Selle B, Niemeyer C, Ehl S (2006) A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol 176:5060–5068PubMedCrossRefGoogle Scholar
  91. 91.
    Engels EA, Pfeiffer RM, Fraumeni JF Jr., Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:1891–1901PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Engels EA, Pittaluga S, Whitby D, Rabkin C, Aoki Y, Jaffe ES, Goedert JJ (2003) Immunoblastic lymphoma in persons with AIDS-associated Kaposi’s sarcoma: a role for Kaposi’s sarcoma-associated herpesvirus. Mod Pathol 16:424–429PubMedCrossRefGoogle Scholar
  93. 93.
    Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1:702–703PubMedCrossRefGoogle Scholar
  94. 94.
    Fajgenbaum DC, van Rhee F, Nabel CS (2014) HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood 123:2924–2933PubMedCrossRefGoogle Scholar
  95. 95.
    Fallah M, Liu X, Ji J, Forsti A, Sundquist K, Hemminki K (2014) Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol 25:2025–2030CrossRefPubMedGoogle Scholar
  96. 96.
    Fallah M, Liu X, Ji J, Forsti A, Sundquist K, Hemminki K (2014) Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype. Ann Oncol 25:1397–1404PubMedCrossRefGoogle Scholar
  97. 97.
    Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W, Delecluse HJ (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. Embo J 19:3080–3089PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Feng S, Jin P, Zeng X (2008) Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Eur J Dermatol 18:364–365PubMedGoogle Scholar
  99. 99.
    Ferreiro JF, Morscio J, Dierickx D, Marcelis L, Verhoef G, Vandenberghe P, Tousseyn T, Wlodarska I (2015) Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern. Haematologica 100:e275–e279PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Ferry JA, Jacobson JO, Conti D, Delmonico F, Harris NL (1989) Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mod Pathol 2:583–592PubMedPubMedCentralGoogle Scholar
  101. 101.
    Fischer E, Delibrias C, Kazatchkine MD (1991) Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146:865–869PubMedPubMedCentralGoogle Scholar
  102. 102.
    Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, Holahan KP, Lindquist LL (1981) Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:4262–4279PubMedPubMedCentralGoogle Scholar
  103. 103.
    Fujimoto M, Haga H, Okamoto M, Obara E, Ishihara M, Mizuta N, Nishimura K, Manabe T (2008) EBV-associated diffuse large B-cell lymphoma arising in the chest wall with surgical mesh implant. Pathol Int 58:668–671PubMedCrossRefPubMedCentralGoogle Scholar
  104. 104.
    Fukayama M, Ibuka T, Hayashi Y, Ooba T, Koike M, Mizutani S (1993) Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol 143:1044–1049PubMedPubMedCentralGoogle Scholar
  105. 105.
    Gaidano G, Capello D, Cilia AM, Gloghini A, Perin T, Quattrone S, Migliazza A, Lo CF, Saglio G, Ascoli V, Carbone A (1999) Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesis. Genes Chromosomes Cancer 24:16–23PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Gebauer N, Gebauer J, Hardel TT, Bernard V, Biersack H, Lehnert H, Rades D, Feller AC, Thorns C (2015) Prevalence of targetable oncogenic mutations and genomic alterations in Epstein-Barr virus-associated diffuse large B-cell lymphoma of the elderly. Leuk Lymphoma 56:1100–6PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Gelb AB, van de Rijn M, Regula DP Jr., Cornbleet JP, Kamel OW, Horoupian DS, Cleary ML, Warnke RA (1994) Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol 25:953–960PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Gibson SE, Hsi ED (2009) Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol 40:653–661PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Gibson SE, Swerdlow SH, Craig FE, Surti U, Cook JR, Nalesnik MA, Lowe C, Wood KM, Bacon CM (2011) EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder? Am J Surg Pathol 35:807–815PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA (2014) Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS 28:2313–2318PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Giffin L, Damania B (2014) KSHV: pathways to tumorigenesis and persistent infection. Adv Virus Res 88:111–159PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Gonzalez-Farre B, Rovira J, Martinez D, Valera A, Garcia-Herrera A, Marcos MA, Sole C, Roue G, Colomer D, Gonzalvo E, Ribera-Cortada I, Araya M, Lloreta J, Colomo L, Campo E, Lopez-Guillermo A, Martinez A (2014) In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications. Mod Pathol 27:1599–1611PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Goyal RK, McEvoy L, Wilson DB (1996) Hodgkin disease after renal transplantation in childhood. J Pediatr Hematol Oncol 18:392–395PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Grier JT, Forbes LR, Monaco-Shawver L, Oshinsky J, Atkinson TP, Moody C, Pandey R, Campbell KS, Orange JS (2012) Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity. J Clin Invest 122:3769–3780PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Grulich AE, Vajdic CM, Cozen W (2007) Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16:405–408PubMedCrossRefPubMedCentralGoogle Scholar
  116. 116.
    Gruver AM, Huba MA, Dogan A, Hsi ED (2012) Fibrin-associated large B-cell lymphoma: part of the spectrum of cardiac lymphomas. Am J Surg Pathol 36:1527–1537PubMedCrossRefPubMedCentralGoogle Scholar
  117. 117.
    Gulley ML, Chen CL, Raab-Traub N (1993) Epstein-Barr virus-related lymphomagenesis in a child with Wiskott-Aldrich syndrome. Hematol Oncol 11:139–145PubMedCrossRefPubMedCentralGoogle Scholar
  118. 118.
    Gupta G, Man I, Kemmett D (2000) Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol 42:208–213PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Gupta G, Mohamed M, Kemmett D (1999) Familial hydroa vacciniforme. Br J Dermatol 140:124–126PubMedCrossRefPubMedCentralGoogle Scholar
  120. 120.
    Ha SY, Sung J, Ju H, Karube K, Kim SJ, Kim WS, Seto M, Ko YH (2013) Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study. Pathol Res Pract 209:448–454PubMedCrossRefPubMedCentralGoogle Scholar
  121. 121.
    Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur DC, Balfour HH Jr., McClain K, Simmons RL, Najarian JS (1983) Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 198:356–369PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Harris NL, Ferry JA, Swerdlow SH (1997) Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol 14:8–14PubMedPubMedCentralGoogle Scholar
  123. 123.
    Hart M, Thakral B, Yohe S, Balfour HH Jr., Singh C, Spears M, McKenna RW (2014) EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder. Am J Surg Pathol 38:1522–1529PubMedCrossRefPubMedCentralGoogle Scholar
  124. 124.
    Hartmann S, Jakobus C, Rengstl B, Doring C, Newrzela S, Brodt HR, Wolf T, Hansmann ML (2013) Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma. Mod Pathol 26:648–657PubMedCrossRefPubMedCentralGoogle Scholar
  125. 125.
    Hashimoto A, Chiba N, Tsuno H, Komiya A, Furukawa H, Matsui T, Nishino J, Tohma S (2014) Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population. J Rheumatol 42:564–571CrossRefGoogle Scholar
  126. 126.
    Hatta K, Morimoto A, Ishii E, Kimura H, Ueda I, Hibi S, Todo S, Sugimoto T, Imashuku S (2007) Association of transforming growth factor-beta1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases. Haematologica 92:1470–1474PubMedCrossRefPubMedCentralGoogle Scholar
  127. 127.
    Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124–131PubMedCrossRefPubMedCentralGoogle Scholar
  128. 128.
    Herndier BG, Sanchez HC, Chang KL, Chen YY, Weiss LM (1993) High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin’s disease. Am J Pathol 142:1073–1079PubMedPubMedCentralGoogle Scholar
  129. 129.
    Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE (2011) Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Am J Gastroenterol 106:2146–2153PubMedCrossRefPubMedCentralGoogle Scholar
  130. 130.
    Hislop AD, Palendira U, Leese AM, Arkwright PD, Rohrlich PS, Tangye SG, Gaspar HB, Lankester AC, Moretta A, Rickinson AB (2010) Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets. Blood 116:3249–3257PubMedCrossRefPubMedCentralGoogle Scholar
  131. 131.
    Hochberg D, Middeldorp JM, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA (2004) Demonstration of the Burkitt’s lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A 101:239–244PubMedCrossRefPubMedCentralGoogle Scholar
  132. 132.
    Hoffmann C, Hentrich M, Gillor D, Behrens G, Jensen B, Stoehr A, Esser S, van Lunzen J, Krznaric I, Muller M, Oette M, Hensel M, Thoden J, Fatkenheuer G, Wyen C (2015) Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study. Hiv Med 16:261–264PubMedCrossRefPubMedCentralGoogle Scholar
  133. 133.
    Hofscheier A, Ponciano A, Bonzheim I, Adam P, Lome-Maldonado C, Vela T, Cortes E, Ortiz-Hidalgo C, Fend F, Quintanilla-Martinez L (2011) Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population. Mod Pathol 24:1046–1054PubMedCrossRefPubMedCentralGoogle Scholar
  134. 134.
    Hollander P, Rostgaard K, Smedby KE, Chang ET, Amini RM, de Nully Brown P, Glimelius B, Adami HO, Melbye M, Glimelius I, Hjalgrim H (2015) Autoimmune and atopic disorders and risk of classical hodgkin lymphoma. Am J Epidemiol 182:624–632PubMedPubMedCentralCrossRefGoogle Scholar
  135. 135.
    Hollingsworth HC, Stetler-Stevenson M, Gagneten D, Kingma DW, Raffeld M, Jaffe ES (1994) Immunodeficiency-associated malignant lymphoma. Three cases showing genotypic evidence of both T- and B-cell lineages. Am J Surg Pathol 18:1092–1101PubMedCrossRefPubMedCentralGoogle Scholar
  136. 136.
    Hong JY, Yoon DH, Suh C, Huh J, Do IG, Sohn I, Jo J, Jung SH, Hong ME, Yoon H, Ko YH, Kim SJ, Kim WS (2015) EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity? Ann Oncol 26:548–555PubMedCrossRefPubMedCentralGoogle Scholar
  137. 137.
    Hong M, Ko YH, Yoo KH, Koo HH, Kim SJ, Kim WS, Park H (2013) EBV-positive T/NK-cell lymphoproliferative disease of childhood. Korean J Pathol 47:137–147PubMedPubMedCentralCrossRefGoogle Scholar
  138. 138.
    Hongyo T, Kurooka M, Taniguchi E, Iuchi K, Nakajima Y, Aozasa K, Nomura T (1998) Frequent p53 mutations at dipyrimidine sites in patients with pyothorax-associated lymphoma. Cancer Res 58:1105–1107PubMedPubMedCentralGoogle Scholar
  139. 139.
    Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E (1997) Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8. Blood 90:1186–1191PubMedPubMedCentralGoogle Scholar
  140. 140.
    Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, Nakatsuka S, Tamaru J, Iizuka A, Takeuchi T, Aozasa K (2007) Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34:322–331PubMedPubMedCentralGoogle Scholar
  141. 141.
    Huang Q, Chang KL, Gaal KK, Weiss LM (2004) KSHV/HHV8-associated lymphoma simulating anaplastic large cell lymphoma. Am J Surg Pathol 28:693–697PubMedCrossRefPubMedCentralGoogle Scholar
  142. 142.
    Hudnall SD, Ge Y, Wei L, Yang NP, Wang HQ, Chen T (2005) Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 18:519–527PubMedCrossRefPubMedCentralGoogle Scholar
  143. 143.
    Hughes CR, Guasti L, Meimaridou E, Chuang CH, Schimenti JC, King PJ, Costigan C, Clark AJ, Metherell LA (2012) MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J Clin Invest 122:814–820PubMedPubMedCentralCrossRefGoogle Scholar
  144. 144.
    Ibrahim HA, Menasce LP, Pomplun S, Burke M, Bower M, Naresh KN (2011) Presence of monoclonal T-cell populations in B-cell post-transplant lymphoproliferative disorders. Mod Pathol 24:232–240PubMedCrossRefPubMedCentralGoogle Scholar
  145. 145.
    Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, Kimura Y, Takeuchi M, Yoshida M, Ishibashi Y, Nakashima S, Sugita Y, Miura O, Ohshima K (2013) Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91:20–28CrossRefPubMedPubMedCentralGoogle Scholar
  146. 146.
    Imashuku S (2002) Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44:259–272PubMedCrossRefPubMedCentralGoogle Scholar
  147. 147.
    Ishihara S, Ohshima K, Tokura Y, Yabuta R, Imaishi H, Wakiguchi H, Kurashige T, Kishimoto H, Katayama I, Okada S, Kawa-Ha K (1997) Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res 88:82–87PubMedPubMedCentralCrossRefGoogle Scholar
  148. 148.
    Ishihara S, Yabuta R, Tokura Y, Ohshima K, Tagawa S (2000) Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease. Int J Hematol 72:223–228PubMedPubMedCentralGoogle Scholar
  149. 149.
    Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, Yamamoto K, Horiuchi H, Takada K, Ohshima K, Nakamura S, Kinukawa N, Oshimi K, Kawa K (2007) Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 86:58–65PubMedCrossRefPubMedCentralGoogle Scholar
  150. 150.
    Ito T, Makishima H, Nakazawa H, Kobayashi H, Shimodaira S, Nakazawa Y, Kitano K, Matsuda K, Hidaka E, Ishida F (2008) Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation. Eur J Haematol 81:107–111PubMedCrossRefPubMedCentralGoogle Scholar
  151. 151.
    Iuchi K, Aozasa K, Yamamoto S, Mori T, Tajima K, Minato K, Mukai K, Komatsu H, Tagaki T, Kobashi Y et al (1989) Non-Hodgkin’s lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. Jpn J Clin Oncol 19:249–257PubMedPubMedCentralGoogle Scholar
  152. 152.
    Iwatsuki K, Ohtsuka M, Akiba H, Kaneko F (1999) Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy. J Am Acad Dermatol 40:283–284PubMedCrossRefPubMedCentralGoogle Scholar
  153. 153.
    Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K (2006) Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 142:587–595PubMedCrossRefPubMedCentralGoogle Scholar
  154. 154.
    Iwatsuki K, Xu Z, Takata M, Iguchi M, Ohtsuka M, Akiba H, Mitsuhashi Y, Takenoshita H, Sugiuchi R, Tagami H, Kaneko F (1999) The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol 140:715–721PubMedCrossRefPubMedCentralGoogle Scholar
  155. 155.
    Janka GE, Lehmberg K (2014) Hemophagocytic syndromes – an update. Blood Rev 28:135–142CrossRefPubMedPubMedCentralGoogle Scholar
  156. 156.
    Jeon YK, Kim JH, Sung JY, Han JH, Ko YH (2015) Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features. Hum Pathol 46:981–990PubMedCrossRefPubMedCentralGoogle Scholar
  157. 157.
    Jhala DN, Medeiros LJ, Lopez-Terrada D, Jhala NC, Krishnan B, Shahab I (2000) Neutrophil-rich anaplastic large cell lymphoma of T-cell lineage. A report of two cases arising in HIV-positive patients. Am J Clin Pathol 114:478–482PubMedCrossRefPubMedCentralGoogle Scholar
  158. 158.
    Jhuang JY, Chang ST, Weng SF, Pan ST, Chu PY, Hsieh PP, Wei CH, Chou SC, Koo CL, Chen CJ, Hsu JD, Chuang SS (2015) Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors. Hum Pathol 46:313–321PubMedPubMedCentralCrossRefGoogle Scholar
  159. 159.
    Johnson LR, Nalesnik MA, Swerdlow SH (2006) Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Am J Surg Pathol 30:1604–1612PubMedCrossRefPubMedCentralGoogle Scholar
  160. 160.
    Kagami Y, Sobue R, Ito N, Yatabe Y, Taji H, Suzuki R, Seto M, Ogura M, Suchi T, Morishima Y, Nakamura S (1999) Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two cases. Int J Hematol 70:105–111PubMedPubMedCentralGoogle Scholar
  161. 161.
    Kageyama R, Cannons JL, Zhao F, Yusuf I, Lao C, Locci M, Schwartzberg PL, Crotty S (2012) The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development. Immunity 36:986–1002PubMedPubMedCentralCrossRefGoogle Scholar
  162. 162.
    Kameda K, Shono T, Takagishi S, Kono S, Aoki T, Ito Y, Kamimura T, Sugita Y, Ohshima K (2015) Epstein-Barr virus-positive diffuse large B-cell primary central nervous system lymphoma associated with organized chronic subdural hematoma: a case report and review of the literature. Pathol Int 65:138–143PubMedCrossRefPubMedCentralGoogle Scholar
  163. 163.
    Kamel OW, van de Rijn M, Weiss LM, Del Zoppo GJ, Hench PK, Robbins BA, Montgomery PG, Warnke RA, Dorfman RF (1993) Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328:1317–1321PubMedCrossRefPubMedCentralGoogle Scholar
  164. 164.
    Kanno H, Nakatsuka S, Iuchi K, Aozasa K (2000) Sequences of cytotoxic T-lymphocyte epitopes in the Epstein-Barr virus (EBV) nuclear antigen-3B gene in a Japanese population with or without EBV-positive lymphoid malignancies. Int J Cancer 88:626–632PubMedCrossRefPubMedCentralGoogle Scholar
  165. 165.
    Kanno H, Ohsawa M, Hashimoto M, Iuchi K, Nakajima Y, Aozasa K (1999) HLA-A alleles of patients with pyothorax-associated lymphoma: anti-Epstein-Barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas. Int J Cancer 82:630–634PubMedCrossRefPubMedCentralGoogle Scholar
  166. 166.
    Kaplan J, De Domenico I, Ward DM (2008) Chediak-Higashi syndrome. Curr Opin Hematol 15:22–29PubMedCrossRefPubMedCentralGoogle Scholar
  167. 167.
    Kaplan MA, Ferry JA, Harris NL, Jacobson JO (1994) Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers. Am J Clin Pathol 101:590–596PubMedCrossRefPubMedCentralGoogle Scholar
  168. 168.
    Katano H, Ali MA, Patera AC, Catalfamo M, Jaffe ES, Kimura H, Dale JK, Straus SE, Cohen JI (2004) Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood 103:1244–1252PubMedCrossRefPubMedCentralGoogle Scholar
  169. 169.
    Kato H, Karube K, Yamamoto K, Takizawa J, Tsuzuki S, Yatabe Y, Kanda T, Katayama M, Ozawa Y, Ishitsuka K, Okamoto M, Kinoshita T, Ohshima K, Nakamura S, Morishima Y, Seto M (2014) Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways. Cancer Sci 105:537–544PubMedPubMedCentralCrossRefGoogle Scholar
  170. 170.
    Kato S, Asano N, Miyata-Takata T, Takata K, Elsayed AA, Satou A, Takahashi E, Kinoshita T, Nakamura S (2015) T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases. Am J Surg Pathol 39:462–471PubMedCrossRefPubMedCentralGoogle Scholar
  171. 171.
    Kato S, Takahashi E, Asano N, Tanaka T, Megahed N, Kinoshita T, Nakamura S (2012) Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases. Histopathology 61:186–199PubMedCrossRefPubMedCentralGoogle Scholar
  172. 172.
    Katz G, Krummey SM, Larsen SE, Stinson JR, Snow AL (2014) SAP facilitates recruitment and activation of LCK at NTB-A receptors during restimulation-induced cell death. J Immunol 192:4202–4209PubMedCrossRefPubMedCentralGoogle Scholar
  173. 173.
    Kim SJ, Jung HA, Chuang SS, Hong H, Guo CC, Cao J, Hong XN, Suzuki R, Kang HJ, Won JH, Chng WJ, Kwong YL, Suh C, Song YQ, Zhu J, Tay K, Lim ST, Suzumiya J, Lin TY, Kim WS (2013) Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group. J Hematol Oncol 6:86PubMedPubMedCentralCrossRefGoogle Scholar
  174. 174.
    Kimura H (2006) Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 16:251–261PubMedCrossRefPubMedCentralGoogle Scholar
  175. 175.
    Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S (2012) EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 119:673–686PubMedCrossRefGoogle Scholar
  176. 176.
    Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, Tsuchiya S, Yachie A, Imashuku S, Kawa K, Wakiguchi H (2003) Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 187:527–533PubMedCrossRefGoogle Scholar
  177. 177.
    Klein U, Gloghini A, Gaidano G, Chadburn A, Cesarman E, Dalla-Favera R, Carbone A (2003) Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101:4115–4121PubMedCrossRefGoogle Scholar
  178. 178.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW (2009) Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. J Clin Oncol 27:3354–3362PubMedCrossRefGoogle Scholar
  179. 179.
    Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552–565PubMedGoogle Scholar
  180. 180.
    Knowlton ER, Lepone LM, Li J, Rappocciolo G, Jenkins FJ, Rinaldo CR (2012) Professional antigen presenting cells in human herpesvirus 8 infection. Front Immunol 3:427PubMedGoogle Scholar
  181. 181.
    Ko YH, Park S, Kim K, Kim SJ, Kim WS (2008) Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis? Acta Haematol 120:199–206PubMedCrossRefGoogle Scholar
  182. 182.
    Koenig G, Stevens TM, Peker D (2015) Plasmablastic microlymphoma arising in human herpesvirus-8-associated multicentric Castleman disease in a human immunodeficiency virus-seronegative patient with clinical response to anti-interleukin-6 therapy. Histopathology 67:930–932PubMedCrossRefGoogle Scholar
  183. 183.
    Koens L, Senff NJ, Vermeer MH, Willemze R, Jansen PM (2014) Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: a clinicopathologic and immunophenotypical study of 10 cases. Am J Surg Pathol 38:999–1006PubMedCrossRefGoogle Scholar
  184. 184.
    Koeppen H, Newell K, Baunoch DA, Vardiman JW (1998) Morphologic bone marrow changes in patients with posttransplantation lymphoproliferative disorders. Am J Surg Pathol 22:208–214PubMedCrossRefGoogle Scholar
  185. 185.
    Kogawa K, Sato H, Asano T, Ohga S, Kudo K, Morimoto A, Ohta S, Wakiguchi H, Kanegane H, Oda M, Ishii E (2014) Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer 61:1257–1262PubMedCrossRefGoogle Scholar
  186. 186.
    Koh KN, Im HJ, Chung NG, Cho B, Kang HJ, Shin HY, Lyu CJ, Yoo KH, Koo HH, Kim HJ, Baek HJ, Kook H, Yoon HS, Lim YT, Kim HS, Ryu KH, Seo JJ (2015) Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party. Eur J Haematol 94:51–59PubMedCrossRefGoogle Scholar
  187. 187.
    Konuma T, Uchimaru K, Sekine R, Ohno N, Soda Y, Tomonari A, Ooi J, Nagamura F, Takahashi S, Iseki T, Oyaizu N, Tojo A, Asano S (2005) Atypical hypersensitivity to mosquito bites without natural killer cell proliferative disease in an adult patient. Int J Hematol 82:441–444PubMedCrossRefGoogle Scholar
  188. 188.
    Kotlyar DS, Osterman MT, Diamond RH, Porter D, Blonski WC, Wasik M, Sampat S, Mendizabal M, Lin MV, Lichtenstein GR (2011) A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 9:36–41e31PubMedCrossRefGoogle Scholar
  189. 189.
    Kutok JL, Wang F (2006) Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 1:375–404PubMedCrossRefGoogle Scholar
  190. 190.
    Kwong YL, Chan AC, Liang R, Chiang AK, Chim CS, Chan TK, Todd D, Ho FC (1997) CD56+ NK lymphomas: clinicopathological features and prognosis. Br J Haematol 97:821–829PubMedCrossRefGoogle Scholar
  191. 191.
    Kwong YL, Wong KF, Chan LC, Liang RH, Chan JK, Lin CK, Chan TK (1995) Large granular lymphocyte leukemia. A study of nine cases in a Chinese population. Am J Clin Pathol 103:76–81PubMedCrossRefGoogle Scholar
  192. 192.
    Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ (1997) Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 100:1969–1979PubMedPubMedCentralCrossRefGoogle Scholar
  193. 193.
    Lebbe C, Porcher R, Marcelin AG, Agbalika F, Dussaix E, Samuel D, Varnous S, Euvrard S, Bigorie A, Creusvaux H, Legendre C, Frances C (2013) Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant 13:207–213PubMedCrossRefGoogle Scholar
  194. 194.
    Leblond V, Davi F, Charlotte F, Dorent R, Bitker MO, Sutton L, Gandjbakhch I, Binet JL, Raphael M (1998) Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 16:2052–2059PubMedCrossRefGoogle Scholar
  195. 195.
    Leroy D, Dompmartin A, Michel M, Tack B, Bravard P, Louvet S (1997) Factors influencing the photo-reproduction of hydroa vacciniforme lesions. Photodermatol Photoimmunol Photomed 13:98–102PubMedCrossRefGoogle Scholar
  196. 196.
    Li FY, Chaigne-Delalande B, Kanellopoulou C, Davis JC, Matthews HF, Douek DC, Cohen JI, Uzel G, Su HC, Lenardo MJ (2011) Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 475:471–476PubMedPubMedCentralCrossRefGoogle Scholar
  197. 197.
    Li FY, Chaigne-Delalande B, Su H, Uzel G, Matthews H, Lenardo MJ (2014) XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood 123:2148–2152PubMedPubMedCentralCrossRefGoogle Scholar
  198. 198.
    Liang JH, Lu TX, Tian T, Wang L, Fan L, Xu J, Zhang R, Gong QX, Zhang ZH, Li JY, Xu W (2015) Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma. Clin Microbiol Infect 21:596–602PubMedCrossRefGoogle Scholar
  199. 199.
    Linka RM, Risse SL, Bienemann K, Werner M, Linka Y, Krux F, Synaeve C, Deenen R, Ginzel S, Dvorsky R, Gombert M, Halenius A, Hartig R, Helminen M, Fischer A, Stepensky P, Vettenranta K, Kohrer K, Ahmadian MR, Laws HJ, Fleckenstein B, Jumaa H, Latour S, Schraven B, Borkhardt A (2012) Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases. Leukemia 26:963–971PubMedCrossRefGoogle Scholar
  200. 200.
    Liu Y, Zhang W, An J, Li H, Liu S (2014) Cutaneous intravascular natural killer-cell lymphoma: a case report and review of the literature. Am J Clin Pathol 142:243–247PubMedCrossRefGoogle Scholar
  201. 201.
    Lones MA, Mishalani S, Shintaku IP, Weiss LM, Nichols WS, Said JW (1995) Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer’s ring. Hum Pathol 26:525–530PubMedCrossRefGoogle Scholar
  202. 202.
    Loong F, Chan AC, Ho BC, Chau YP, Lee HY, Cheuk W, Yuen WK, Ng WS, Cheung HL, Chan JK (2010) Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios. Mod Pathol 23:493–501PubMedCrossRefGoogle Scholar
  203. 203.
    Lopez-Olivo MA, Tayar JH, Martinez-Lopez JA, Pollono EN, Cueto JP, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME (2012) Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA 308:898–908PubMedCrossRefPubMedCentralGoogle Scholar
  204. 204.
    Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, Avery DT, Moens L, Cannons JL, Biancalana M, Stoddard J, Ouyang W, Frucht DM, Rao VK, Atkinson TP, Agharahimi A, Hussey AA, Folio LR, Olivier KN, Fleisher TA, Pittaluga S, Holland SM, Cohen JI, Oliveira JB, Tangye SG, Schwartzberg PL, Lenardo MJ, Uzel G (2014) Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency. Nat Immunol 15:88–97PubMedCrossRefPubMedCentralGoogle Scholar
  205. 205.
    Luppi M, Barozzi P, Santagostino G, Trovato R, Schulz TF, Marasca R, Bottalico D, Bignardi L, Torelli G (2000) Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 96:3279–3281PubMedGoogle Scholar
  206. 206.
    Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M (2007) Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr 44:265–267PubMedCrossRefGoogle Scholar
  207. 207.
    Mancao C, Hammerschmidt W (2007) Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110:3715–3721PubMedPubMedCentralCrossRefGoogle Scholar
  208. 208.
    Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011) NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood 117:1447–1452PubMedPubMedCentralCrossRefGoogle Scholar
  209. 209.
    Mariette X, Matucci-Cerinic M, Pavelka K, Taylor P, van Vollenhoven R, Heatley R, Walsh C, Lawson R, Reynolds A, Emery P (2011) Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Ann Rheum Dis 70:1895–1904PubMedCrossRefGoogle Scholar
  210. 210.
    Martin A, Flaman JM, Frebourg T, Davi F, El Mansouri S, Amouroux J, Raphael M (2009) Functional analysis of the p53 protein in AIDS-related non-Hodgkin’s lymphomas and polymorphic lymphoproliferations. Br J Haematol 101:311–317CrossRefGoogle Scholar
  211. 211.
    Massaad MJ, Ramesh N, Geha RS (2013) Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci 1285:26–43PubMedPubMedCentralCrossRefGoogle Scholar
  212. 212.
    Matolcsy A, Nador RG, Cesarman E, Knowles DM (1998) Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Pathol 153:1609–1614PubMedPubMedCentralCrossRefGoogle Scholar
  213. 213.
    Matsushima AY, Strauchen JA, Lee G, Scigliano E, Hale EE, Weisse MT, Burstein D, Kamel O, Moore PS, Chang Y (1999) Posttransplantation plasmacytic proliferations related to Kaposi’s sarcoma-associated herpesvirus. Am J Surg Pathol 23:1393–1400PubMedCrossRefPubMedCentralGoogle Scholar
  214. 214.
    McClain KL, Leach CT, Jenson HB, Joshi VV, Pollock BH, Hutchison RE, Murphy SB (2000) Molecular and virologic characteristics of lymphoid malignancies in children with AIDS. J Acquir Immune Defic Syndr 23:152–159PubMedCrossRefPubMedCentralGoogle Scholar
  215. 215.
    Mercer LK, Davies R, Galloway JB, Low A, Lunt M, Dixon WG, Watson KD, Symmons DP, Hyrich KL (2013) Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. Rheumatology (Oxford) 52:91–98CrossRefGoogle Scholar
  216. 216.
    Miller DV, Firchau DJ, McClure RF, Kurtin PJ, Feldman AL (2010) Epstein-Barr virus-associated diffuse large B-cell lymphoma arising on cardiac prostheses. Am J Surg Pathol 34:377–384PubMedCrossRefPubMedCentralGoogle Scholar
  217. 217.
    Miranda RN, Loo E, Medeiros LJ (2013) Iatrogenic immunodeficiency-associated classical hodgkin lymphoma: clinicopathologic features of 54 cases reported in the literature. Am J Surg Pathol 37:1895–1897PubMedCrossRefPubMedCentralGoogle Scholar
  218. 218.
    Montes-Moreno S, Odqvist L, Diaz-Perez JA, Lopez AB, de Villambrosia SG, Mazorra F, Castillo ME, Lopez M, Pajares R, Garcia JF, Mollejo M, Camacho FI, Ruiz-Marcellan C, Adrados M, Ortiz N, Franco R, Ortiz-Hidalgo C, Suarez-Gauthier A, Young KH, Piris MA (2012) EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation. Mod Pathol 25:968–982PubMedCrossRefPubMedCentralGoogle Scholar
  219. 219.
    Mori N, Yamashita Y, Tsuzuki T, Nakayama A, Nakazawa M, Hasegawa Y, Kojima H, Nagasawa T (2000) Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection. Histopathology 37:363–371PubMedCrossRefPubMedCentralGoogle Scholar
  220. 220.
    Morishima S, Nakamura S, Yamamoto K, Miyauchi H, Kagami Y, Kinoshita T, Onoda H, Yatabe Y, Ito M, Miyamura K, Nagai H, Moritani S, Sugiura I, Tsushita K, Mihara H, Ohbayashi K, Iba S, Emi N, Okamoto M, Iwata S, Kimura H, Kuzushima K, Morishima Y (2015) Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma. Leuk Lymphoma 56:1072–8PubMedCrossRefPubMedCentralGoogle Scholar
  221. 221.
    Morscio J, Dierickx D, Ferreiro JF, Herreman A, Van Loo P, Bittoun E, Verhoef G, Matthys P, Cools J, Wlodarska I, De Wolf-Peeters C, Sagaert X, Tousseyn T (2013) Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders. Am J Transplant 13:1305–1316PubMedCrossRefPubMedCentralGoogle Scholar
  222. 222.
    Moshous D, Pannetier C, Chasseval Rd R, Deist Fl F, Cavazzana-Calvo M, Romana S, Macintyre E, Canioni D, Brousse N, Fischer A, Casanova JL, Villartay JP (2003) Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest 111:381–387PubMedPubMedCentralCrossRefGoogle Scholar
  223. 223.
    Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM (1996) Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood 88:645–656PubMedGoogle Scholar
  224. 224.
    Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM (2003) Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. Am J Surg Pathol 27:293–302PubMedCrossRefPubMedCentralGoogle Scholar
  225. 225.
    Nakajima Y, Waku M, Kojima A, Sato Y, Miyanaga S (1996) Prognosis of the surgical treatment for non-Hodgkin lymphoma originating from chronic tuberculous empyema – analysis of 11 cases with pleuropneumonectomy. Nihon Kyobu Geka Gakkai Zasshi 44:484–492PubMedPubMedCentralGoogle Scholar
  226. 226.
    Nakamura S, Jaffe ES, Swerdlow SH (2008) EBV positive diffuse large B-cell lymphoma of the elderly. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Hrsg) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, S 243–244Google Scholar
  227. 227.
    Nakashima Y, Tagawa H, Suzuki R, Karnan S, Karube K, Ohshima K, Muta K, Nawata H, Morishima Y, Nakamura S, Seto M (2005) Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type. Genes Chromosomes Cancer 44:247–255PubMedPubMedCentralCrossRefGoogle Scholar
  228. 228.
    Nakatsuka S, Yao M, Hoshida Y, Yamamoto S, Iuchi K, Aozasa K (2002) Pyothorax-associated lymphoma: a review of 106 cases. J Clin Oncol 20:4255–4260PubMedCrossRefPubMedCentralGoogle Scholar
  229. 229.
    Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173–192PubMedPubMedCentralGoogle Scholar
  230. 230.
    Nalesnik MA, Randhawa P, Demetris AJ, Casavilla A, Fung JJ, Locker J (1993) Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer 72:2568–2573PubMedCrossRefPubMedCentralGoogle Scholar
  231. 231.
    Narimatsu H, Ota Y, Kami M, Takeuchi K, Suzuki R, Matsuo K, Matsumura T, Yuji K, Kishi Y, Hamaki T, Sawada U, Miyata S, Sasaki T, Tobinai K, Kawabata M, Atsuta Y, Tanaka Y, Ueda R, Nakamura S (2007) Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients. Ann Oncol 18:122–128PubMedCrossRefPubMedCentralGoogle Scholar
  232. 232.
    Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung JJ, Swerdlow SH (2000) Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 24:375–385PubMedCrossRefPubMedCentralGoogle Scholar
  233. 233.
    Nelson BP, Wolniak KL, Evens A, Chenn A, Maddalozzo J, Proytcheva M (2012) Early posttransplant lymphoproliferative disease: clinicopathologic features and correlation with mTOR signaling pathway activation. Am J Clin Pathol 138:568–578PubMedCrossRefPubMedCentralGoogle Scholar
  234. 234.
    Nicolae A, Pittaluga S, Abdullah S, Steinberg SM, Pham TA, Davies-Hill T, Xi L, Raffeld M, Jaffe ES (2015) EBV positive large B cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. Blood 126:863–872PubMedPubMedCentralCrossRefGoogle Scholar
  235. 235.
    Nishiu M, Tomita Y, Nakatsuka S, Takakuwa T, Iizuka N, Hoshida Y, Ikeda J, Iuchi K, Yanagawa R, Nakamura Y, Aozasa K (2004) Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation. Cancer Sci 95:828–834PubMedCrossRefPubMedCentralGoogle Scholar
  236. 236.
    Nomura H, Egami S, Kasai H, Mori M, Yokoyama T, Fujimoto A, Sugiura M, Iwatsuki K (2014) An elderly patient with chronic active Epstein-Barr virus infection with severe hydroa vacciniforme-like eruptions associated with alphabetaT-cell proliferation. J Dermatol 41:360–362PubMedCrossRefPubMedCentralGoogle Scholar
  237. 237.
    Ogimi C, Tanaka R, Arai T, Kikuchi A, Hanada R, Oh-Ishi T (2011) Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome. Pediatr Blood Cancer 57:677–680PubMedCrossRefPubMedCentralGoogle Scholar
  238. 238.
    Oh J, Yoon H, Shin DK, Jang MJ, Kim GI, Chong SY, Oh D (2012) A case of successful management of HHV-8(+), EBV(+) germinotropic lymphoproliferative disorder (GLD). Int J Hematol 95:107–111PubMedCrossRefPubMedCentralGoogle Scholar
  239. 239.
    Ohno H, Nishikori M, Haga H, Isoda K (2009) Epstein-Barr virus-positive diffuse large B-cell lymphoma carrying a t(9;14)(p13;q32) translocation. Int J Hematol 89:704–708PubMedCrossRefPubMedCentralGoogle Scholar
  240. 240.
    Ohsawa M, Tomita Y, Kanno H, Iuchi K, Kawabata Y, Nakajima Y, Komatsu H, Mukai K, Shimoyama M, Aozasa K (1995) Role of Epstein-Barr virus in pleural lymphomagenesis. Mod Pathol 8:848–853PubMedPubMedCentralGoogle Scholar
  241. 241.
    Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK (2008) Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 58:209–217CrossRefPubMedPubMedCentralGoogle Scholar
  242. 242.
    Ohtsuka T, Okita H, Otsuka S, Yamakage A, Yamazaki S (2001) Hydroa vacciniforme with latent Epstein-Barr virus infection. Br J Dermatol 145:509–510PubMedCrossRefPubMedCentralGoogle Scholar
  243. 243.
    Ok CY, Li L, Xu-Monette ZY, Visco C, Tzankov A, Manyam GC, Montes-Moreno S, Dybaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Chen J, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ai W, Ponzoni M, Ferreri AJ, Farnen JP, Moller MB, Bueso-Ramos CE, Miranda RN, Winter JN, Piris MA, Medeiros LJ, Young KH (2014) Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clin Cancer Res 20:2338–2349PubMedPubMedCentralCrossRefGoogle Scholar
  244. 244.
    Ok CY, Papathomas TG, Medeiros LJ, Young KH (2013) EBV-positive diffuse large B-cell lymphoma of the elderly. Blood 122:328–340PubMedPubMedCentralCrossRefGoogle Scholar
  245. 245.
    Okamoto A, Yanada M, Miura H, Inaguma Y, Tokuda M, Morishima S, Kanie T, Yamamoto Y, Mizuta S, Akatsuka Y, Yoshikawa T, Mizoguchi Y, Nakamura S, Okamoto M, Emi N (2015) Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma. Cancer Sci 106:1576–1581PubMedPubMedCentralCrossRefGoogle Scholar
  246. 246.
    Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99:2331–2336PubMedCrossRefPubMedCentralGoogle Scholar
  247. 247.
    Oksenhendler E, Boutboul D, Beldjord K, Meignin V, de Labarthe A, Fieschi C, Dossier A, Agbalika F, Parravicini C, Tosato G, Gerard L, Galicier L (2013) Human herpesvirus 8+ polyclonal IgMlambda B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients. Eur J Haematol 91:497–503PubMedCrossRefPubMedCentralGoogle Scholar
  248. 248.
    Okuda T, Sakamoto S, Deguchi T, Misawa S, Kashima K, Yoshihara T, Ikushima S, Hibi S, Imashuku S (1991) Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. Am J Hematol 38:321–323PubMedCrossRefPubMedCentralGoogle Scholar
  249. 249.
    Opelz G, Dohler B (2004) Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4:222–230PubMedCrossRefPubMedCentralGoogle Scholar
  250. 250.
    Otsuki T, Kumar S, Ensoli B, Kingma DW, Yano T, Stetler-Stevenson M, Jaffe ES, Raffeld M (1996) Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 10:1358–1362PubMedPubMedCentralGoogle Scholar
  251. 251.
    Oudejans JJ, Jiwa M, van den Brule AJ, Grasser FA, Horstman A, Vos W, Kluin PM, van der Valk P, Walboomers JM, Meijer CJ (1995) Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Am J Pathol 147:923–933PubMedPubMedCentralGoogle Scholar
  252. 252.
    Oyama T, Ichimura K, Suzuki R, Suzumiya J, Ohshima K, Yatabe Y, Yokoi T, Kojima M, Kamiya Y, Taji H, Kagami Y, Ogura M, Saito H, Morishima Y, Nakamura S (2003) Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 27:16–26PubMedCrossRefPubMedCentralGoogle Scholar
  253. 253.
    Oyama T, Yamamoto K, Asano N, Oshiro A, Suzuki R, Kagami Y, Morishima Y, Takeuchi K, Izumo T, Mori S, Ohshima K, Suzumiya J, Nakamura N, Abe M, Ichimura K, Sato Y, Yoshino T, Naoe T, Shimoyama Y, Kamiya Y, Kinoshita T, Nakamura S (2007) Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 13:5124–5132PubMedCrossRefPubMedCentralGoogle Scholar
  254. 254.
    Pacheco SE, Gottschalk SM, Gresik MV, Dishop MK, Okmaura T, McCormick TG (2005) Chronic active Epstein-Barr virus infection of natural killer cells presenting as severe skin reaction to mosquito bites. J Allergy Clin Immunol 116:470–472PubMedCrossRefPubMedCentralGoogle Scholar
  255. 255.
    Palendira U, Low C, Bell AI, Ma CS, Abbott RJ, Phan TG, Riminton DS, Choo S, Smart JM, Lougaris V, Giliani S, Buckley RH, Grimbacher B, Alvaro F, Klion AD, Nichols KE, Adelstein S, Rickinson AB, Tangye SG (2012) Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus. J Exp Med 209:913–924PubMedPubMedCentralCrossRefGoogle Scholar
  256. 256.
    Palendira U, Low C, Chan A, Hislop AD, Ho E, Phan TG, Deenick E, Cook MC, Riminton DS, Choo S, Loh R, Alvaro F, Booth C, Gaspar HB, Moretta A, Khanna R, Rickinson AB, Tangye SG (2011) Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. Plos Biol 9:e1001187PubMedPubMedCentralCrossRefGoogle Scholar
  257. 257.
    Palenzuela G, Bernard F, Gardiner Q, Mondain M (2003) Malignant B cell non-Hodgkin’s lymphoma of the larynx in children with Wiskott Aldrich syndrome. Int J Pediatr Otorhinolaryngol 67:989–993PubMedCrossRefPubMedCentralGoogle Scholar
  258. 258.
    Pan ZG, Zhang QY, Lu ZB, Quinto T, Rozenvald IB, Liu LT, Wilson D, Reddy V, Huang Q, Wang HY, Ren YS (2012) Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases. Am J Surg Pathol 36:1129–1140PubMedCrossRefPubMedCentralGoogle Scholar
  259. 259.
    Papoudou-Bai A, Hatzimichael E, Kyriazopoulou L, Briasoulis E, Kanavaros P (2015) Rare variants in the spectrum of human herpesvirus 8/Epstein-Barr virus-copositive lymphoproliferations. Hum Pathol 46:1566–1571PubMedCrossRefPubMedCentralGoogle Scholar
  260. 260.
    Park S, Bahng S, Kim EK, Park SB, Sung YK, Kim SJ, Kim WS, Ko YH (2010) Hodgkin’s lymphoma arising in a patient with hypersensitivity to mosquito bites: a case report. J Clin Oncol 28:e148–150PubMedCrossRefPubMedCentralGoogle Scholar
  261. 261.
    Park S, Kim K, Kim WS, Yoo KH, Koo HH, Ko YH (2008) Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients. Virchows Arch 453:155–163PubMedPubMedCentralCrossRefGoogle Scholar
  262. 262.
    Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC, Hwang IG, Park YH, Ahn JS, Jung CW, Kim K, Ahn YC, Kang WK, Park K, Kim WS (2007) The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 110:972–978PubMedCrossRefPubMedCentralGoogle Scholar
  263. 263.
    Pati S, Foulke JS Jr., Barabitskaya O, Kim J, Nair BC, Hone D, Smart J, Feldman RA, Reitz M (2003) Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. J Virol 77:5759–5773PubMedPubMedCentralCrossRefGoogle Scholar
  264. 264.
    Petitjean B, Jardin F, Joly B, Martin-Garcia N, Tilly H, Picquenot JM, Briere J, Danel C, Mehaut S, Abd-Al-Samad I, Copie-Bergman C, Delfau-Larue MH, Gaulard P (2002) Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype. Am J Surg Pathol 26:724–732PubMedCrossRefPubMedCentralGoogle Scholar
  265. 265.
    Picarsic J, Jaffe R, Mazariegos G, Webber SA, Ellis D, Green MD, Reyes-Mugica M (2011) Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder. Cancer 117:4540–4550PubMedCrossRefPubMedCentralGoogle Scholar
  266. 266.
    Poirel HA, Bernheim A, Schneider A, Meddeb M, Choquet S, Leblond V, Charlotte F, Davi F, Canioni D, Macintyre E, Mamzer-Bruneel MF, Hirsch I, Hermine O, Martin A, Cornillet-Lefebvre P, Patey M, Toupance O, Kemeny JL, Deteix P, Raphael M (2005) Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status. Transplantation 80:176–184PubMedCrossRefPubMedCentralGoogle Scholar
  267. 267.
    Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, Perkins K, Hornung RL, Folio L, Rosenberg PS, Puck JM, Hsu AP, Lo B, Pittaluga S, Jaffe ES, Fleisher TA, Rao VK, Lenardo MJ (2014) Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood 123:1989–1999PubMedPubMedCentralCrossRefGoogle Scholar
  268. 268.
    Purushothaman P, Uppal T, Verma SC (2015) Molecular biology of KSHV lytic reactivation. Viruses 7:116–153PubMedPubMedCentralCrossRefGoogle Scholar
  269. 269.
    Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES (2000) Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96:443–451PubMedPubMedCentralGoogle Scholar
  270. 270.
    Quintanilla-Martinez L, Ridaura C, Nagl F, Saez-de-Ocariz M, Duran-McKinster C, Ruiz-Maldonado R, Alderete G, Grube P, Lome-Maldonado C, Bonzheim I, Fend F (2013) Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Blood 122:3101–3110PubMedCrossRefPubMedCentralGoogle Scholar
  271. 271.
    Rickinson AB, Kieff E (2007) Epstein-Barr Virus. In: Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE (Hrsg) Fields virology. Lippincott-Williams & Wilkins, Philadelphia, S 2655–2700Google Scholar
  272. 272.
    Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444:110–114PubMedCrossRefPubMedCentralGoogle Scholar
  273. 273.
    Rodriguez-Pinilla SM, Barrionuevo C, Garcia J, de los AM, Pajares R, Casavilca S, Montes J, Martinez A, Montes-Moreno S, Sanchez L, Piris MA (2011) Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases. Histopathology 59:1183–1193PubMedCrossRefPubMedCentralGoogle Scholar
  274. 274.
    Rosh JR, Gross T, Mamula P, Griffiths A, Hyams J (2007) Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn’s disease: a cautionary tale? Inflamm Bowel Dis 13:1024–1030PubMedCrossRefPubMedCentralGoogle Scholar
  275. 275.
    Rowlings PA, Curtis RE, Passweg JR, Deeg HJ, Socie G, Travis LB, Kingma DW, Jaffe ES, Sobocinski KA, Horowitz MM (1999) Increased incidence of Hodgkin’s disease after allogeneic bone marrow transplantation. J Clin Oncol 17:3122–3127PubMedCrossRefPubMedCentralGoogle Scholar
  276. 276.
    Ruiz-Maldonado R, Parrilla FM, Orozco-Covarrubias ML, Ridaura C, Tamayo Sanchez L, Duran McKinster C (1995) Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential. J Am Acad Dermatol 32:37–44PubMedCrossRefPubMedCentralGoogle Scholar
  277. 277.
    Said JW, Shintaku IP, Asou H, deVos S, Baker J, Hanson G, Cesarman E, Nador R, Koeffler HP (1999) Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype. Arch Pathol Lab Med 123:257–260PubMedPubMedCentralGoogle Scholar
  278. 278.
    Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, Knowles DM, Koeffler HP (1996) Primary effusion lymphoma in women: report of two cases of Kaposi’s sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 88:3124–3128PubMedPubMedCentralGoogle Scholar
  279. 279.
    Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, Schultz M, Murren J (1996) Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14:1943–1949PubMedCrossRefPubMedCentralGoogle Scholar
  280. 280.
    Salzer E, Daschkey S, Choo S, Gombert M, Santos-Valente E, Ginzel S, Schwendinger M, Haas OA, Fritsch G, Pickl WF, Forster-Waldl E, Borkhardt A, Boztug K, Bienemann K, Seidel MG (2013) Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica 98:473–478PubMedPubMedCentralCrossRefGoogle Scholar
  281. 281.
    Sasajima Y, Yamabe H, Kobashi Y, Hirai K, Mori S (1993) High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas. Am J Pathol 143:1280–1285PubMedPubMedCentralGoogle Scholar
  282. 282.
    Sato A, Nakamura N, Kojima M, Ohmachi K, Carreras J, Kikuti YY, Numata H, Ohgiya D, Tazume K, Amaki J, Moriuchi M, Miyamoto M, Aoyama Y, Kawai H, Ichiki A, Hara R, Kawada H, Ogawa Y, Ando K (2014) Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era. Cancer Sci 105:1170–1175PubMedPubMedCentralCrossRefGoogle Scholar
  283. 283.
    Schiff M, Jillson OF (1960) Photoskin tests in hydroa vacciniforme. Arch Dermatol 82:812–816PubMedCrossRefPubMedCentralGoogle Scholar
  284. 284.
    Sebire NJ, Haselden S, Malone M, Davies EG, Ramsay AD (2003) Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol 56:555–557PubMedPubMedCentralCrossRefGoogle Scholar
  285. 285.
    Seliem RM, Griffith RC, Harris NL, Beheshti J, Schiffman FJ, Longtine J, Kutok J, Ferry JA (2007) HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands. Am J Surg Pathol 31:1439–1445PubMedCrossRefPubMedCentralGoogle Scholar
  286. 286.
    Sharifi R, Sinclair JC, Gilmour KC, Arkwright PD, Kinnon C, Thrasher AJ, Gaspar HB (2004) SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood 103:3821–3827PubMedCrossRefPubMedCentralGoogle Scholar
  287. 287.
    Shiels MS, Koritzinsky EH, Clarke CA, Suneja G, Morton LM, Engels EA (2014) Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases. Cancer Epidemiol Biomarkers Prev 23:274–281PubMedCrossRefPubMedCentralGoogle Scholar
  288. 288.
    Shimoyama Y, Yamamoto K, Asano N, Oyama T, Kinoshita T, Nakamura S (2008) Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci 99:1085–1091PubMedCrossRefPubMedCentralGoogle Scholar
  289. 289.
    Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S (2015) Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther 17:212PubMedPubMedCentralCrossRefGoogle Scholar
  290. 290.
    Sinclair AJ (2003) bZIP proteins of human gammaherpesviruses. J Gen Virol 84:1941–1949PubMedCrossRefPubMedCentralGoogle Scholar
  291. 291.
    Soler J, Bordes R, Ortuno F, Montagud M, Martorell J, Pons C, Nomdedeu J, Lopez-Lopez JJ, Prat J, Rutllant M (1994) Aggressive natural killer cell leukaemia/lymphoma in two patients with lethal midline granuloma. Br J Haematol 86:659–662PubMedCrossRefPubMedCentralGoogle Scholar
  292. 292.
    Song JY, Jaffe ES (2013) HHV-8-positive but EBV-negative primary effusion lymphoma. Blood 122:3712PubMedPubMedCentralCrossRefGoogle Scholar
  293. 293.
    Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, Arthur DC, Gu W, Gould CM, Brewer CC, Cowen EW, Freeman AF, Olivier KN, Uzel G, Zelazny AM, Daub JR, Spalding CD, Claypool RJ, Giri NK, Alter BP, Mace EM, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM (2014) GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123:809–821PubMedPubMedCentralCrossRefGoogle Scholar
  294. 294.
    Steger GG, Dittrich C, Honigsmann H, Moser K (1988) Permanent cure of hydroa vacciniforme after chemotherapy for Hodgkin’s disease. Br J Dermatol 119:684–685PubMedCrossRefPubMedCentralGoogle Scholar
  295. 295.
    Stray-Pedersen A, Jouanguy E, Crequer A, Bertuch AA, Brown BS, Jhangiani SN, Muzny DM, Gambin T, Sorte H, Sasa G, Metry D, Campbell J, Sockrider MM, Dishop MK, Scollard DM, Gibbs RA, Mace EM, Orange JS, Lupski JR, Casanova JL, Noroski LM (2014) Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy. J Clin Immunol 34:871–890PubMedPubMedCentralCrossRefGoogle Scholar
  296. 296.
    Su IJ, Hsu YH, Lin MT, Cheng AL, Wang CH, Weiss LM (1993) Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 72:2019–2027PubMedCrossRefGoogle Scholar
  297. 297.
    Su IJ, Lin DT, Hsieh HC, Lee SH, Chen J, Chen RL, Lee CY, Chen JY (1990) Fatal primary Epstein-Barr virus infection masquerading as histiocytic medullary reticulosis in young children in Taiwan. Hematol Pathol 4:189–195PubMedGoogle Scholar
  298. 298.
    Suarez F, Mahlaoui N, Canioni D, Andriamanga C, Dubois d’Enghien C, Brousse N, Jais JP, Fischer A, Hermine O, Stoppa-Lyonnet D (2015) Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol 33:202–208PubMedCrossRefGoogle Scholar
  299. 299.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M (2004) Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol 24:1165–1174PubMedGoogle Scholar
  300. 300.
    Suzuki R, Suzumiya J, Nakamura S, Aoki S, Notoya A, Ozaki S, Gondo H, Hino N, Mori H, Sugimori H, Kawa K, Oshimi K (2004) Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 18:763–770PubMedPubMedCentralCrossRefGoogle Scholar
  301. 301.
    Suzuki R, Suzumiya J, Nakamura S, Kagami Y, Kameoka JI, Sakai C, Mukai H, Takenaka K, Yoshino T, Tsuzuki T, Sugimori H, Kawa K, Kodera Y, Oshimi K (2006) Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transpl 37:425–431CrossRefGoogle Scholar
  302. 302.
    Swerdlow SH (2007) T-cell and NK-cell posttransplantation lymphoproliferative disorders. Am J Clin Pathol 127:887–895PubMedCrossRefGoogle Scholar
  303. 303.
    Tabiasco J, Vercellone A, Meggetto F, Hudrisier D, Brousset P, Fournie JJ (2003) Acquisition of viral receptor by NK cells through immunological synapse. J Immunol 170:5993–5998PubMedCrossRefGoogle Scholar
  304. 304.
    Takahashi E, Asano N, Li C, Tanaka T, Shimada K, Shimada S, Yoshino T, Kojima M, Hara K, Eimoto T, Nakamura S (2008) Nodal T/NK-cell lymphoma of nasal type: a clinicopathological study of six cases. Histopathology 52:585–596PubMedCrossRefGoogle Scholar
  305. 305.
    Takakuwa T, Ham MF, Luo WJ, Nakatsuka S, Daibata M, Aozasa K (2006) Loss of expression of Epstein-Barr virus nuclear antigen-2 correlates with a poor prognosis in cases of pyothorax-associated lymphoma. Int J Cancer 118:2782–2789PubMedCrossRefGoogle Scholar
  306. 306.
    Takakuwa T, Tresnasari K, Rahadiani N, Miwa H, Daibata M, Aozasa K (2008) Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein-Barr virus infection. Leukemia 22:620–627PubMedCrossRefGoogle Scholar
  307. 307.
    Takeuchi K, Yokoyama M, Ishizawa S, Terui Y, Nomura K, Marutsuka K, Nunomura M, Fukushima N, Yagyuu T, Nakamine H, Akiyama F, Hoshi K, Matsue K, Hatake K, Oshimi K (2010) Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood 116:5631–5637PubMedCrossRefGoogle Scholar
  308. 308.
    Tangye SG (2014) XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. J Clin Immunol 34:772–779PubMedCrossRefGoogle Scholar
  309. 309.
    Tao J, Valderrama E (1999) Epstein-Barr virus-associated polymorphic B-cell lymphoproliferative disorders in the lungs of children with AIDS: a report of two cases. Am J Surg Pathol 23:560–566PubMedCrossRefGoogle Scholar
  310. 310.
    Taris M, de Mascarel A, Riols M, Delwail V, Milpied N, Dubus P, Parrens M (2014) KHSV/EBV associated germinotropic lymphoproliferative disorder: a rare entity, case report and review of the literature. Ann Pathol 34:373–377PubMedCrossRefPubMedCentralGoogle Scholar
  311. 311.
    Teruya-Feldstein J, Temeck BK, Sloas MM, Kingma DW, Raffeld M, Pass HI, Mueller B, Jaffe ES (1995) Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. Am J Surg Pathol 19:357–363PubMedCrossRefPubMedCentralGoogle Scholar
  312. 312.
    Teruya-Feldstein J, Zauber P, Setsuda JE, Berman EL, Sorbara L, Raffeld M, Tosato G, Jaffe ES (1998) Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman’s disease and primary effusion lymphoma. Lab Invest 78:1637–1642PubMedPubMedCentralGoogle Scholar
  313. 313.
    Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328–1337PubMedCrossRefPubMedCentralGoogle Scholar
  314. 314.
    Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M (2013) The pathogenesis of Epstein-Barr virus persistent infection. Curr Opin Virol 3:227–232PubMedPubMedCentralCrossRefGoogle Scholar
  315. 315.
    Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M (2001) Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol 45:569–578PubMedCrossRefPubMedCentralGoogle Scholar
  316. 316.
    Tosato G, Straus S, Henle W, Pike SE, Blaese RM (1985) Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). J Immunol 134:3082–3088PubMedPubMedCentralGoogle Scholar
  317. 317.
    Trappe R, Zimmermann H, Fink S, Reinke P, Dreyling M, Pascher A, Lehmkuhl H, Gartner B, Anagnostopoulos I, Riess H (2011) Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases. Haematologica 96:1067–1071PubMedPubMedCentralCrossRefGoogle Scholar
  318. 318.
    Trappe RU, Choquet S, Dierickx D, Mollee P, Zaucha JM, Dreyling MH, Duhrsen U, Tarella C, Shpilberg O, Sender M, Salles G, Morschhauser F, Jaccard A, Lamy T, Reinke P, Neuhaus R, Lehmkuhl H, Horst HA, Leithauser M, Schlattmann P, Anagnostopoulos I, Raphael M, Riess H, Leblond V, Oertel S (2015) International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial. Am J Transplant 15:1091–1100PubMedCrossRefPubMedCentralGoogle Scholar
  319. 319.
    Tsuge I, Morishima T, Kimura H, Kuzushima K, Matsuoka H (2001) Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection. J Med Virol 64:141–148PubMedCrossRefPubMedCentralGoogle Scholar
  320. 320.
    Uldrick TS, Little RF (2015) How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus. Blood 125(1355):1226–1235PubMedPubMedCentralCrossRefGoogle Scholar
  321. 321.
    Uldrick TS, Polizzotto MN, Yarchoan R (2012) Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Curr Opin Oncol 24:495–505PubMedCrossRefGoogle Scholar
  322. 322.
    Vakiani E, Basso K, Klein U, Mansukhani MM, Narayan G, Smith PM, Murty VV, Dalla-Favera R, Pasqualucci L, Bhagat G (2008) Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. Hematol Oncol 26:199–211PubMedCrossRefGoogle Scholar
  323. 323.
    Vakiani E, Nandula SV, Subramaniyam S, Keller CE, Alobeid B, Murty VV, Bhagat G (2007) Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion. Hum Pathol 38:315–325PubMedCrossRefGoogle Scholar
  324. 324.
    Valli R, Froio E, Alvarez de Celis MI, Mandato VD, Piana S (2014) Diffuse large B-cell lymphoma occurring in an ovarian cystic teratoma: expanding the spectrum of large B-cell lymphoma associated with chronic inflammation. Hum Pathol 45:2507–2511PubMedCrossRefPubMedCentralGoogle Scholar
  325. 325.
    Valli R, Piana S, Capodanno I, Cavazza A (2011) Diffuse large B-cell lymphoma associated with chronic inflammation arising in a renal pseudocyst. Int J Surg Pathol 19:117–119PubMedCrossRefPubMedCentralGoogle Scholar
  326. 326.
    Vase MO, Maksten EF, Bendix K, Hamilton-Dutoit S, Andersen C, Moller MB, Sorensen SS, Jespersen B, Kampmann J, Sondergard E, Nielsen PS, D’Amore F (2015) Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders. Leuk Lymphoma 56:1677–1685PubMedCrossRefGoogle Scholar
  327. 327.
    Veettil MV, Bandyopadhyay C, Dutta D, Chandran B (2014) Interaction of KSHV with host cell surface receptors and cell entry. Viruses 6:4024–4046PubMedPubMedCentralCrossRefGoogle Scholar
  328. 328.
    Webber SA (1999) Post-transplant lymphoproliferative disorders: a preventable complication of solid organ transplantation? Pediatr Transplant 3:95–99PubMedCrossRefGoogle Scholar
  329. 329.
    Webber SA, Naftel DC, Fricker FJ, Olesnevich P, Blume ED, Addonizio L, Kirklin JK, Canter CE (2006) Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet 367:233–239PubMedCrossRefGoogle Scholar
  330. 330.
    Wiesner M, Zentz C, Mayr C, Wimmer R, Hammerschmidt W, Zeidler R, Moosmann A (2008) Conditional immortalization of human B cells by CD40 ligation. PLoS ONE 3:e1464PubMedPubMedCentralCrossRefGoogle Scholar
  331. 331.
    Wolf T, Brodt HR, Fichtlscherer S, Mantzsch K, Hoelzer D, Helm EB, Mitrou PS, Chow KU (2005) Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin’s lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 46:207–215PubMedCrossRefPubMedCentralGoogle Scholar
  332. 332.
    Wolfe F, Michaud K (2007) The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum 56:1433–1439PubMedCrossRefPubMedCentralGoogle Scholar
  333. 333.
    Wong AK, Kerkoutian S, Said J, Rashidi H, Pullarkat ST (2012) Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies. Clin Rheumatol 31:631–636PubMedCrossRefGoogle Scholar
  334. 334.
    Wu TT, Swerdlow SH, Locker J, Bahler D, Randhawa P, Yunis EJ, Dickman PS, Nalesnik MA (1996) Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol 27:157–164PubMedCrossRefPubMedCentralGoogle Scholar
  335. 335.
    Wu YH, Chen HC, Hsiao PF, Tu MI, Lin YC, Wang TY (2007) Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child. Int J Dermatol 46:1081–1086PubMedCrossRefPubMedCentralGoogle Scholar
  336. 336.
    Xie J, Zhou X, Zhang X, Zheng Y, Yue B (2015) Primary intravascular natural killer/T cell lymphoma of the central nervous system. Leuk Lymphoma 56:1154–1156PubMedCrossRefPubMedCentralGoogle Scholar
  337. 337.
    Yamada K, Oshiro Y, Okamura S, Fujisaki T, Kondo S, Nakayama Y, Suematsu E, Tamura K, Takeshita M (2015) Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders. Histopathology 67:70–80PubMedCrossRefPubMedCentralGoogle Scholar
  338. 338.
    Yamato H, Ohshima K, Suzumiya J, Kikuchi M (2001) Evidence for local immunosuppression and demonstration of c-myc amplification in pyothorax-associated lymphoma. Histopathology 39:163–171PubMedCrossRefPubMedCentralGoogle Scholar
  339. 339.
    Yoon H, Park S, Ju H, Ha SY, Sohn I, Jo J, Do IG, Min S, Kim SJ, Kim WS, Yoo HY, Ko YH (2015) Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma. Genes Chromosomes Cancer 54:383–396PubMedCrossRefPubMedCentralGoogle Scholar
  340. 340.
    Zhao F, Cannons JL, Dutta M, Griffiths GM, Schwartzberg PL (2012) Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis. Immunity 36:1003–1016PubMedPubMedCentralCrossRefGoogle Scholar
  341. 341.
    Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM (1988) Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520–529PubMedPubMedCentralGoogle Scholar
  342. 342.
    Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD (2015) The immunology of Epstein–Barr virus-induced disease. Annu Rev Immunol 33:787–821PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Ioannis Anagnostopoulos
    • 1
  • Leticia Quintanilla de Fend
    • 2
  1. 1.Institut für PathologieUniversitätsklinikum Carl Gustav CarusDresdenDeutschland
  2. 2.Institut für Pathologie und Neuropathologie, Abteilung Allgemeine PathologieEberhard-Karls-Universität TübingenTübingenDeutschland

Personalised recommendations